AQST - CIK 0001398733
Aquestive Therapeutics, Inc. has filed 641 documents with the SEC between 2007 and 2026. The most frequent type is insider trade (265 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2024-05-13 | 2024-05-10 |
| Insider trade | 4 | 2024-05-13 | 2024-05-10 |
| Major company event | 8-K | 2024-05-08 | 2024-05-07 |
| Quarterly report | 10-Q | 2024-05-07 | 2024-03-31 |
| Major company event | 8-K | 2024-05-07 | 2024-05-07 |
| Major company event | 8-K | 2024-04-29 | 2024-04-26 |
| New insider ownership | 3 | 2024-04-26 | 2024-04-01 |
| Annual report to shareholders | ARS | 2024-04-26 | 2023-12-31 |
| Proxy materials | DEFA14A | 2024-04-26 | - |
| Proxy statement | DEF 14A | 2024-04-26 | 2024-06-20 |
| Prospectus supplement | 424B2 | 2024-04-24 | - |
| Prospectus supplement | 424B2 | 2024-04-24 | - |
| EFFECT | - | 2024-04-23 | - |
| Major company event | 8-K | 2024-04-22 | 2024-04-22 |
| Company correspondence | CORRESP | 2024-04-19 | - |
| Company correspondence | CORRESP | 2024-04-19 | - |
| Company correspondence | CORRESP | 2024-04-16 | - |
| SEC correspondence | UPLOAD | 2024-04-08 | - |
| Securities registration | S-3 | 2024-04-03 | - |
| Major company event | 8-K | 2024-04-01 | 2024-04-01 |
| Passive ownership stake | SC 13G | 2024-04-01 | - |
| Major company event | 8-K | 2024-03-21 | 2024-03-19 |
| Prospectus supplement | 424B5 | 2024-03-21 | - |
| Insider trade | 4 | 2024-03-19 | 2024-03-15 |
| Prospectus supplement | 424B5 | 2024-03-19 | - |
| Insider sale notice | 144 | 2024-03-15 | - |
| Major company event | 8-K | 2024-03-15 | 2024-03-14 |
| Insider trade | 4 | 2024-03-12 | 2024-03-09 |
| Insider trade | 4 | 2024-03-12 | 2024-03-09 |
| Insider trade | 4 | 2024-03-12 | 2024-03-09 |
| Insider trade | 4 | 2024-03-12 | 2024-03-09 |
| Insider trade | 4 | 2024-03-12 | 2024-03-09 |
| Insider trade | 4 | 2024-03-12 | 2024-03-09 |
| Insider trade | 4 | 2024-03-12 | 2024-03-08 |
| Insider trade | 4 | 2024-03-11 | 2024-03-07 |
| Insider trade | 4 | 2024-03-11 | 2024-03-07 |
| Insider trade | 4 | 2024-03-11 | 2024-03-07 |
| Insider trade | 4 | 2024-03-11 | 2024-03-07 |
| Insider trade | 4 | 2024-03-11 | 2024-03-07 |
| Insider trade | 4 | 2024-03-11 | 2023-03-10 |
| Insider trade | 4 | 2024-03-11 | 2024-03-07 |
| Insider trade | 4 | 2024-03-11 | 2023-03-10 |
| Insider sale notice | 144 | 2024-03-08 | - |
| Annual report | 10-K | 2024-03-05 | 2023-12-31 |
| Major company event | 8-K | 2024-03-05 | 2024-03-05 |
| Passive ownership stake | SC 13G | 2024-02-14 | - |
| Employee stock plan | S-8 | 2024-02-12 | - |
| SEC correspondence | UPLOAD | 2023-12-19 | - |
| Company correspondence | CORRESP | 2023-12-13 | - |
| Major company event | 8-K | 2023-12-08 | 2023-12-07 |